Arc Antikörper (AA 191-208)
Kurzübersicht für Arc Antikörper (AA 191-208) (ABIN1731925)
Target
Alle Arc Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 191-208
-
Spezifität
- Reacts with human ARC.
-
Aufreinigung
- Purified
-
Immunogen
- Peptide corresponding to aa 191-208 of human ARC.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
IHC (5 μg/mL) WB(1 - 10 μg/mL) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Dilute in PBS or medium that is identical to that used in the assay system.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Arc (Activity-Regulated Cytoskeleton-Associated Protein (Arc))
-
Andere Bezeichnung
- ARC
-
Hintergrund
-
A novel CARD domain-containing protein was recently identified and designated ARC (apoptosis repressor with CARD). ARC interacts with caspase-2 and -8 and inhibits enzymatic activity of caspase-8. ARC suppresses apoptosis induced by cell death adapters FADD and TRADD and by cell death receptors Fas, TNFR-1, and DR3. The messenger RNA of ARC is primarily expressed in skeletal muscle and cardiac tissue.
Nucleolar protein 3 Apoptosis repressor with CARD Muscle-enriched cytoplasmic protein, Myp Nucleolar protein of 30 kDa, Nop30 Gene name: NOL3, NOP -
Gen-ID
- 8996
-
UniProt
- O60936
Target
-